<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Review of the policy on foreign Direct Investment (FDI) in Pharmaceutical Sector-carve out for medical devices.</title>
    <link>https://www.taxtmi.com/circulars?id=53161</link>
    <description>The policy permits full foreign direct investment under the automatic route for manufacturing of medical devices, and the pharmaceutical-sector brownfield and greenfield conditions will not apply to medical device projects. The Press Note provides a detailed definition of &quot;medical device,&quot; including instruments, accessories and in vitro diagnostic reagents and systems, and notes the definition is subject to amendment in the Drugs and Cosmetics Act. Usual pharmaceutical controls such as non compete restrictions and FIPB certificate requirements continue to apply to pharmaceuticals generally.</description>
    <language>en-us</language>
    <pubDate>Tue, 06 Jan 2015 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 06 Jan 2015 15:17:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=373368" rel="self" type="application/rss+xml"/>
    <item>
      <title>Review of the policy on foreign Direct Investment (FDI) in Pharmaceutical Sector-carve out for medical devices.</title>
      <link>https://www.taxtmi.com/circulars?id=53161</link>
      <description>The policy permits full foreign direct investment under the automatic route for manufacturing of medical devices, and the pharmaceutical-sector brownfield and greenfield conditions will not apply to medical device projects. The Press Note provides a detailed definition of &quot;medical device,&quot; including instruments, accessories and in vitro diagnostic reagents and systems, and notes the definition is subject to amendment in the Drugs and Cosmetics Act. Usual pharmaceutical controls such as non compete restrictions and FIPB certificate requirements continue to apply to pharmaceuticals generally.</description>
      <category>Circulars</category>
      <law>FEMA</law>
      <pubDate>Tue, 06 Jan 2015 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/circulars?id=53161</guid>
    </item>
  </channel>
</rss>